Scrip
Cephalon and Barr settle US Fentora patent dispute
19 November 2009
Nancy Faigen
Cephalon has entered into an agreement-in-principle whereby it will give Barr Pharmaceuticals (now part of
Teva Pharmaceuticals Industries) a licence to sell a generic version of the pain therapy, Fentora (fentanyl buccal tablets), in 2018 as part of a patent lawsuit settlement, according to a recent...
Please Login to read the full article.
19 November 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
